newsfilter
← Latest News
PR Newswire·

Aadi Bioscience to Participate in Upcoming Investor Events

LOS ANGELES, May 23, 2023 /PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ:AADI), a commercial-stage biopharmaceutical company focused on developing and commercializing precision therapies for genetically-defined cancers